Successful treatment of acute lung injury with pitavastatin in septic mice: Potential role of glucocorticoid receptor expression in alveolar macrophages

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 2, 2011, Pages 381-390

  Takano, Ken Ichi ^a   Yamamoto, Seiji ^a   Tomita, Kengo ^a   Takashina, Michinori ^a   Yokoo, Hiroki ^a   Matsuda, Naoyuki ^a   Takano, Yasuo ^a   Hattori, Yuichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PITAVASTATIN;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HYDROCORTISONE BLOOD LEVEL; HYPOTENSION; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPSIS;

ACUTE LUNG INJURY; ANIMALS; APOPTOSIS; CYTOKINES; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; QUINOLINES; RECEPTORS, GLUCOCORTICOID; SEPSIS;

EID: 78751488978     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.171462     Document Type: Article

References (41)

1. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA, and Ware LB (2002) Fas and Fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161:1783-1796.
2. Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, and Danon A (2004) Prior statin therapy is associated with a decreased rate of sepsis. Circulation 110:880-885. (Pubitemid 39096018)
3. Baschant U and Tuckermann J (2010) The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 120:69-75.
4. Bhatia M and Moochhala S (2004) Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202:145-156.
5. Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, and Bernini F (1999) New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther 84:413-428.
6. Das UN (2000) Critical advances in septicemia and septic shock. Crit Care 4:290-296.
7. Elder A, Johnston C, Gelein R, Finkelstein J, Wang Z, Notter R, and Oberdörster G (2005) Lung inflammation induced by endotoxin is enhanced in rats depleted of alveolar macrophages with aerosolized clodronate. Exp Lung Res 31:527-546.
8. Ferguson ND, Frutos-Vivar F, Esteban A, Fernández-Segoviano P, Aramburu JA, Nájera L, and Stewart TE (2005) Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med 33:2228-2234.
9. Geissmann F, Jung S, and Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82.
10. Goldstein JL and Brown MS (2009) The LDL receptor. Arterioscler Thromb Vasc Biol 29:431-438.
11. Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, and Orme IM (2003) Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol 171:3128-3135.
12. Greenwood J and Mason JC (2007) Statins and the vascular endothelial inflammatory response. Trends Immunol 28:88-98. (Pubitemid 46178495)
13. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, and Chaudry IH. (2005) Cecal ligation and puncture. Shock 24 (Suppl 1):52-57.
14. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, and Garcia JG (2005) Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 288:L1026-L1032.
15. Jakubzick C, Tacke F, Llodra J, van Rooijen N, and Randolph GJ (2006) Modulation of dendritic cell trafficking to and from the airways. J Immunol 176:3578-3584.
16. Jones RG, Elford AR, Parsons MJ, Wu L, Krawczyk CM, Yeh WC, Hakem R, Rottapel R, Woodgett JR, and Ohashi PS (2002) CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J Exp Med 196:335-348.
17. Kajinami K, Takekoshi N, and Saito Y (2003) Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor. Cardiovasc Drug Rev 21:199-215.
18. Kamiyama K, Matsuda N, Yamamoto S, Takano K, Takano Y, Yamazaki H, Kageyama S, Yokoo H, Nagata T, Hatakeyama N, et al. (2008) Modulation of glucocorticoid receptor expression, inflammation, and cell apoptosis in septic guinea pig lungs using methylprednisolone. Am J Physiol Lung Cell Mol Physiol 295:L998-L1006.
19. Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, van Rooijen N, and van der Poll T (2003) Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med 167:171-179.
20. Kooguchi K, Hashimoto S, Kobayashi A, Kitamura Y, Kudoh I, Wiener-Kronish J, and Sawa T (1998) Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect Immun 66:3164-3169.
21. Kwak B, Mulhaupt F, Myit S, and Mach F (2000) Statins as a newly recognized type of immunomodulator. Nat Med 6:1399-1402. (Pubitemid 32001026)
22. Lambrecht BN (2006) Alveolar macrophage in the driver's seat. Immunity 24:366-368.
23. Liu SF and Malik AB (2006) NF-κB activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290:L622-L645.
24. Matsuda N, Hattori Y, Jesmin S, and Gando S (2005) Nuclear factor-κB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis. Mol Pharmacol 67:1018-1025. (Pubitemid 40410404)
25. Matsuda N, Hayashi Y, Takahashi Y, and Hattori Y (2006) Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy. J Pharmacol Exp Ther 319:1348-1354.
26. Matsuda N, Takano Y, Kageyama S, Hatakeyama N, Shakunaga K, Kitajima I, Yamazaki M, and Hattori Y (2007) Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock. Cardiovasc Res 76:132-140.
27. Matsuda N, Yamamoto S, Takano K, Kageyama S, Kurobe Y, Yoshihara Y, Takano Y, and Hattori Y (2009a) Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis. Am J Respir Crit Care Med 179:806-815.
28. Matsuda N, Yamamoto S, Yokoo H, Tobe K, and Hattori Y (2009b) Nuclear factor-κB decoy oligodeoxynucleotides ameliorate impaired glucose tolerance and insulin resistance in mice with cecal ligation and puncture-induced sepsis. Crit Care Med 37:2791-2799.
29. Merx MW, Liehn EA, Janssens U, Lütticken R, Schrader J, Hanrath P, and Weber C (2004) HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 109:2560-2565.
30. Nakamura T, Abu-Dahab R, Menger MD, Schäfer U, Vollmar B, Wada H, Lehr CM, and Schäfers HJ (2005) Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung. J Heart Lung Transplant 24:38-45.
31. Perl M, Chung CS, Lomas-Neira J, Rachel TM, Biffl WL, Cioffi WG, and Ayala A (2005) Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am J Pathol 167:1545-1559.
32. Probst HC, Tschannen K, Odermatt B, Schwendener R, Zinkernagel RM, and Van Den Broek M (2005) Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp Immunol 141:398-404.
33. Robertson CM and Coopersmith CM (2006) The systemic inflammatory response syndrome. Microbes Infect 8:1382-1389.
34. Romano M, Diomede L, Sironi M, Massimiliano L, Sottocorno M, Polentarutti N, Guglielmotti A, Albani D, Bruno A, Fruscella P, et al. (2000) Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab Invest 80:1095-1100.
35. 2-integrins. Am J Physiol Lung Cell Mol Physiol 292:L469-L475.
36. 4). J Histochem Cytochem 38:1683-1686.
37. Thepen T, Van Rooijen N, and Kraal G (1989) Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 170:499-509.
38. Tsiotou AG, Sakorafas GH, Anagnostopoulos G, and Bramis J. (2005) Septic shock; current pathogenetic concepts from a clinical perspective. Med Sci Monit 11: RA76-RA85.
39. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D, et al. (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344-353.
40. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, and Hommel U (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7:687-692. (Pubitemid 32588024)
41. Yao HW, Mao LG, and Zhu JP (2006) Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clin Exp Pharmacol Physiol 33:793-797.